(Q31116047)

29 June 2017

title

Aseptic meningitis: case definition and guidelines for collection, analysis and presentation of immunization safety data (English)

1 reference

29 June 2017

0 references

1 reference

1 reference

1 reference

6

Jan Bonhoeffer

1 reference

29 June 2017

21

James Sejvar

1 reference

29 June 2017

13

Ulrich Heininger

1 reference

29 June 2017

10

Paul Gillard

1 reference

29 June 2017

17

Najwa Khuri-Bulos

1 reference

29 June 2017

1

Terhi Tapiainen

1 reference

29 June 2017

2

Rebecca Prevots

1 reference

29 June 2017

18

S Michael Marcy

1 reference

29 June 2017

Hector S Izurieta

3

1 reference

29 June 2017

Jon Abramson

4

1 reference

29 June 2017

Roman Bilynsky

5

1 reference

29 June 2017

Marie-Claude Bonnet

7

1 reference

29 June 2017

Kimberly Center

8

1 reference

29 June 2017

Jochem Galama

9

1 reference

29 June 2017

Monika Griot

11

1 reference

29 June 2017

Katharina Hartmann

12

1 reference

29 June 2017

Michael Hudson

14

1 reference

29 June 2017

Annette Koller

15

1 reference

29 June 2017

Nino Khetsuriani

16

1 reference

29 June 2017

Raimonda Matulionyte

19

1 reference

29 June 2017

Ines Schöndorf

20

1 reference

29 June 2017

Russell Steele

22

1 reference

29 June 2017

Brighton Collaboration Aseptic Meningitis Working Group

23

1 reference

29 June 2017

language of work or name

English

0 references

publication date

8 May 2007

1 reference

29 June 2017

1 reference

29 June 2017

volume

25

1 reference

29 June 2017

issue

31

1 reference

29 June 2017

page(s)

5793-5802

1 reference

A season of aseptic meningitis in Germany: epidemiologic, clinical and diagnostic aspects

29 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Impact of a diagnostic cerebrospinal fluid enterovirus polymerase chain reaction test on patient management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Multiple-year experience in the diagnosis of viral central nervous system infections with a panel of polymerase chain reaction assays for detection of 11 viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Meningitis in a community with a high prevalence of tuberculosis and HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Lyme disease in children in southeastern Connecticut. Pediatric Lyme Disease Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Aseptic meningitis caused by Mycoplasma pneumoniae in a 19-year-old woman

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Leukemic meningitis in B-cell prolymphocytic leukemia. A clinical, pathologic, and ultrastructural case study and a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Trimethoprim-induced aseptic meningitis in an adolescent male

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Encephalitis and aseptic meningitis, Olmsted County, Minnesota, 1950-1981: I. Epidemiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Vaccine-associated poliovirus meningitis in children with ventriculoperitoneal shunts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Outbreak of aseptic meningitis associated with mass vaccination with a urabe-containing measles-mumps-rubella vaccine: implications for immunization programs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

The risk of aseptic meningitis associated with the Leningrad-Zagreb mumps vaccine strain following mass vaccination with measles-mumps-rubella vaccine, Rio Grande do Sul, Brazil, 1997

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Risk analysis of aseptic meningitis after measles-mumps-rubella vaccination in Korean children by using a case-crossover design.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Risk of hospitalization because of aseptic meningitis after measles-mumps-rubella vaccination in one- to two-year-old children: an analysis of the Vaccine Safety Datalink (VSD) Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Neurologic disorders after measles-mumps-rubella vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the Leningrad-Zagreb mumps strain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Aseptic meningitis following mumps vaccine. A retrospective survey by the French Regional Pharmacovigilance centres and by Pasteur-Mérieux Sérums & Vaccins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Measles-rubella mass immunization campaign in Albania, November 2000.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

[Clinical and laboratory features of aseptic meningitis associated with measles-mumps-rubella vaccine]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Surveillance of measles-mumps-rubella vaccine-associated aseptic meningitis in Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Safety evaluation of MMR vaccine during a primary school campaign in Saudi Arabia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Aseptic meningitis after measles, mumps, and rubella vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Outbreak of aseptic meningitis associated with echovirus 13.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Acute meningitis with a negative Gram's stain: clinical and management outcomes in 171 episodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Characterization of Lyme meningitis and comparison with viral meningitis in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

The cytology of the normal cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Lymphocyte phenotype and subset distribution in normal cerebrospinal fluid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Normal Laboratory Values of CSF During Pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Cerebrospinal fluid values in the term neonate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Reference values of normal cerebrospinal fluid composition in infants ages 0 to 8 weeks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Practice guidelines for the management of bacterial meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Cerebrospinal fluid investigations in tuberculous meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

C-reactive protein is useful in distinguishing Gram stain-negative bacterial meningitis from viral meningitis in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

The use of C-reactive protein from cerebrospinal fluid for differentiating meningitis from other central nervous system diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Postictal cerebrospinal fluid abnormalities in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Cerebrospinal fluid findings in aseptic versus bacterial meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Laboratory diagnosis of bacterial meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Lack of sensitivity of the latex agglutination test to detect bacterial antigen in the cerebrospinal fluid of patients with culture-negative meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Cerebrospinal latex agglutination fails to contribute to the microbiologic diagnosis of pretreated children with meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Infection with wild-type mumps virus in army recruits temporally associated with MMR vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Measles inclusion-body encephalitis caused by the vaccine strain of measles virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Rapid RT-PCR amplification of full-length poliovirus genomes allows rapid discrimination between wild-type and recombinant vaccine-derived polioviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

The vaccine origin of the 1968 epidemic of type 3 poliomyelitis in Poland.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Long-term circulation of vaccine-derived poliovirus that causes paralytic disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Studies of measles viruses circulating in Australia between 1999 and 2001 reveals a new genotype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

An Emergent Poxvirus from Humans and Cattle in Rio de Janeiro State: Cantagalo Virus May Derive from Brazilian Smallpox Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

Detection of Leptospira DNA in patients with aseptic meningitis by PCR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.058

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2007.04.058

1 reference

29 June 2017

1 reference